Obagi Medical launched Sun Shield™ Mineral UV Barrier Protect SPF 40, a mineral sunscreen supporting skin health and UV protection.
Quiver AI Summary
Obagi Medical has launched Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40, a new mineral sunscreen designed to provide broad-spectrum UVA/UVB protection while enhancing skin health. This lightweight, non-comedogenic formula, ideal for sensitive or acne-prone skin, incorporates 100% mineral active filters, antioxidants, ceramides, and squalane to soothe, hydrate, and support the skin barrier. With the rise in consumer preference for mineral-based sunscreens, Obagi aims to meet market demands by combining effective sun protection with restorative skincare benefits. Priced at $65, the product is available on Obagi.com, Amazon, and through authorized providers.
Potential Positives
- Obagi has launched a new product, Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40, which is a clinically proven mineral sunscreen that aligns with the growing consumer preference for mineral-based skincare.
- The formulation incorporates skin-supporting ingredients such as ceramides and squalane, catering to a specific market segment that includes individuals with sensitive, acne-prone, and post-procedure skin.
- This product reflects Obagi's commitment to high-performance skincare solutions, strengthening its position in the competitive suncare market while addressing concerns about premature skin aging and discoloration.
- With the launch of this innovative sunscreen, Obagi reinforces its reputation as a leader in medical-grade skincare, leveraging over 35 years of experience and expertise in the beauty and wellness industry.
Potential Negatives
- None
FAQ
What is the latest product launched by Obagi Medical?
The latest product launched by Obagi Medical is the Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 sunscreen.
What are the key ingredients in Sun Shield™ mineral sunscreen?
Key ingredients include 100% mineral active filters, antioxidants, ceramides, and squalane.
Who is the target audience for this new sunscreen?
The sunscreen is ideal for sensitive, acne-prone, and post-procedure skin.
Where can I purchase Sun Shield™ Mineral UV Barrier Protect SPF 40?
It is available on Obagi.com, Amazon.com, and through authorized Obagi Medical providers.
What benefits does this sunscreen provide for skin health?
It offers broad-spectrum UV protection, soothes, hydrates, and supports the skin barrier, while defending against photodamage.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$WALD Hedge Fund Activity
We have seen 28 institutional investors add shares of $WALD stock to their portfolio, and 25 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 745,165 shares (-88.9%) from their portfolio in Q4 2025, for an estimated $1,400,910
- MCADAM, LLC removed 45,264 shares (-71.8%) from their portfolio in Q4 2025, for an estimated $85,096
- SQUAREPOINT OPS LLC removed 39,311 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $73,904
- NORTHERN TRUST CORP removed 39,112 shares (-15.7%) from their portfolio in Q4 2025, for an estimated $73,530
- DEUTSCHE BANK AG\ added 31,341 shares (+264.2%) to their portfolio in Q4 2025, for an estimated $58,921
- BLACKROCK, INC. added 28,383 shares (+1.4%) to their portfolio in Q4 2025, for an estimated $53,360
- CIBC ASSET MANAGEMENT INC added 24,642 shares (+inf%) to their portfolio in Q4 2025, for an estimated $46,326
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$WALD Analyst Ratings
Wall Street analysts have issued reports on $WALD in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/14/2026
- Canaccord Genuity issued a "Buy" rating on 11/25/2025
To track analyst ratings and price targets for $WALD, check out Quiver Quantitative's $WALD forecast page.
$WALD Price Targets
Multiple analysts have issued price targets for $WALD recently. We have seen 3 analysts offer price targets for $WALD in the last 6 months, with a median target of $2.0.
Here are some recent targets:
- Susan Anderson from Canaccord Genuity set a target price of $2.0 on 03/16/2026
- Dana Telsey from Telsey Advisory Group set a target price of $2.0 on 03/16/2026
- Sydney Wagner from Jefferies set a target price of $2.0 on 01/14/2026
Full Release
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced the launch of its latest innovation, Sun Shield ™ Mineral UV Barrier Protect Broad Spectrum SPF 40, a clinically proven mineral sunscreen designed to deliver comprehensive UV protection while supporting skin health.
Formulated with 100% mineral active filters, antioxidants, ceramides, and squalane, this advanced sunscreen provides broad-spectrum UVA/UVB protection while helping to soothe, hydrate, and support the skin barrier. The lightweight, non-comedogenic formula is ideal for sensitive, acne-prone, and post-procedure* skin, making it a versatile addition to any daily skincare regimen.
“This launch represents the continued evolution of Obagi’s suncare portfolio,” said Justin Giouzepis, Chief Marketing Officer. “As the category shifts toward mineral-based, skincare-first protection, we developed this innovation to meet evolving consumer and channel needs while leveraging our medical-grade skincare expertise to strengthen our suncare offering as the first line of defense against premature skin aging and discoloration. This sunscreen delivers effective UV protection and reflects our commitment to high-performance, skincare-first SPF solutions that support a comprehensive daily regimen.”
This new addition to the Obagi Sun Shield ™ portfolio reflects growing consumer demand for mineral-based sunscreens that deliver both efficacy and skin compatibility. According to internal insights, a majority of U.S. sunscreen users prefer mineral formulas, particularly those that support overall skin health and barrier function.
“Sun protection is the foundation of healthy skin, especially following professional treatments or when managing sensitivity,” said Dr. Suzan Obagi, Chief Medical Director. “With Sun Shield ™ Mineral UV Barrier Protect SPF 40, we’ve combined high-performance mineral protection with restorative skincare ingredients to help patients protect and strengthen their skin every day.”
Sun Shield ™ Mineral UV Barrier Protect Broad Spectrum SPF 40 provides broad-spectrum SPF 40 mineral UVA/UVB protection while supporting the skin barrier with ceramides and squalane. The formula also delivers antioxidant defense against photodamage and oxidative stress, and is dermatologist-tested to be lightweight, non-irritating, and non-comedogenic. It is suitable for sensitive, acne-prone, and post-procedure* skin.
Sun Shield ™ Mineral UV Barrier Protect Broad Spectrum SPF 40 is now available for $65 on Obagi.com , Amazon.com , as well as through authorized Obagi Medical providers and select retail channels.
About Obagi Medical
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm
®
System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024**, Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi Medical is available on the brand's website,
https://www.obagi.com
.
About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the Business Combination. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit:
https://ir.waldencast.com
.
Media Contact:
[email protected]
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c1c7fdcd-0ae7-47ae-b896-4dd3d286f4e1